Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 21, 2015 9:10 AM ET

Pharmaceuticals

Company Overview of Euclises Pharmaceuticals, Inc.

Executive Profile

Randy H. Weiss Ph.D.

Chief Executive Officer and President, SARmont, LLC
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.

See Board Relationships
----

Background

Dr. Randy H. Weiss, Ph.D. serves as the Chief Executive Officer and President of SARmont, LLC. Dr. Weiss also serves as the Managing Director at Start-up St. Louis, LLC. He is a Co-Founder of RadTargX Therapeutics, Inc. He served as the Co-Founder and President of Euclises Pharmaceuticals, Inc. He was Partner and Venture Partner at Triathlon Medical Ventures. He served as the Chief Executive Officer of Galera Therapeutics LLC. He served as Chief Executive Officer of ...

Corporate Headquarters

4320 Forest Park Avenue
St. Louis, Missouri 63108

United States

Phone: 314-604-2850
Fax: --

Board Members Memberships

Co-Founder
Director

Education

PhD
Washington University, St. Louis
MBA
Washington University, St. Louis

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Euclises Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.